China

CIRS RD Briefing 102 – Tracking Availability in China of Medicines Approved in Six Key Global Markets

All approved medicines have been rigorously assessed by regulatory authorities to ensure their benefits outweigh the risks. Today, pharmaceutical companies are increasingly focused on integrated global drug development strategies, [...]

2025-09-15T15:16:24+00:00September 16th, 2025|Tags: , |

CIRS RD Briefing 56: Understanding the dynamics of China’s regulatory environment

Changes have occurred in the organisation and procedural activities of the China Food and Drug Administration (CFDA) and the Centre for Drug Evaluation (CDE). Initiatives that were designed to [...]

2024-12-18T16:21:57+00:00June 1st, 2015|Tags: , |
Go to Top